Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H29F3N2O8 |
| Molecular Weight | 542.5016 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@@H]1[C@@H](O)[C@H](OC2=CC=C(OC(F)(F)F)C=C2CN[C@H]3CCCN[C@H]3C4=CC=CC=C4)O[C@@H]([C@H]1O)C(O)=O
InChI
InChIKey=GQQBZEWKUOQAPH-SSHGPHHNSA-N
InChI=1S/C25H29F3N2O8/c26-25(27,28)38-15-8-9-17(36-24-21(33)19(31)20(32)22(37-24)23(34)35)14(11-15)12-30-16-7-4-10-29-18(16)13-5-2-1-3-6-13/h1-3,5-6,8-9,11,16,18-22,24,29-33H,4,7,10,12H2,(H,34,35)/t16-,18-,19-,20-,21+,22-,24+/m0/s1
| Molecular Formula | C25H29F3N2O8 |
| Molecular Weight | 542.5016 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:21:57 GMT 2025
by
admin
on
Wed Apr 02 07:21:57 GMT 2025
|
| Record UNII |
NDL1FEY5R9
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
NDL1FEY5R9
Created by
admin on Wed Apr 02 07:21:57 GMT 2025 , Edited by admin on Wed Apr 02 07:21:57 GMT 2025
|
PRIMARY | |||
|
915205-80-0
Created by
admin on Wed Apr 02 07:21:57 GMT 2025 , Edited by admin on Wed Apr 02 07:21:57 GMT 2025
|
PRIMARY | |||
|
154572881
Created by
admin on Wed Apr 02 07:21:57 GMT 2025 , Edited by admin on Wed Apr 02 07:21:57 GMT 2025
|
PRIMARY | |||
|
DTXSID801025039
Created by
admin on Wed Apr 02 07:21:57 GMT 2025 , Edited by admin on Wed Apr 02 07:21:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
IN EXTENSIVE METABOLIZER HUMAN SUBJECTS
PLASMA
|
||
|
PARENT -> METABOLITE |
IN EXTENSIVE METABOLIZER HUMAN SUBJECTS
URINE
|
